UDR (NYSE:UDR – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.530-0.550 for the period, compared to the consensus earnings per share estimate of 0.610. The company issued revenue guidance of -. UDR also updated its FY 2024 guidance to 2.120-2.240 EPS.
UDR Price Performance
NYSE:UDR traded down $0.21 during trading hours on Tuesday, reaching $38.08. 3,263,255 shares of the company were exchanged, compared to its average volume of 2,946,120. The company has a current ratio of 5.15, a quick ratio of 5.15 and a debt-to-equity ratio of 1.47. The stock’s 50-day moving average is $36.78 and its 200-day moving average is $35.97. The firm has a market cap of $12.54 billion, a PE ratio of 28.55, a price-to-earnings-growth ratio of 3.03 and a beta of 0.80. UDR has a twelve month low of $30.95 and a twelve month high of $44.02.
UDR Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Wednesday, April 10th will be given a dividend of $0.425 per share. The ex-dividend date is Tuesday, April 9th. This is a boost from UDR’s previous quarterly dividend of $0.42. This represents a $1.70 dividend on an annualized basis and a yield of 4.46%. UDR’s dividend payout ratio is currently 126.87%.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on UDR
UDR Company Profile
UDR, Inc (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S.
Featured Articles
- Five stocks we like better than UDR
- Bank Stocks – Best Bank Stocks to Invest In
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Hilton Demonstrates Asset Light is Right for Investors
- What Are the U.K. Market Holidays? How to Invest and Trade
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for UDR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDR and related companies with MarketBeat.com's FREE daily email newsletter.